Answers are grounded in this paper and cite their sources.
Review reveals cardioprotective actions of muscarinic acetylcholine receptor M3 in cardiovascular diseases, highlighting its therapeutic potential against heart failure.
The muscarinic acetylcholine receptor M3 (M3-mAChR) is involved in various physiological and pathological processes. Owing to specific cardioprotective effects, M3-mAChR is an ideal diagnostic and therapeutic biomarker for cardiovascular diseases (CVDs). Growing evidence has linked M3-mAChR to the development of multiple CVDs. This review summarizes the expression patterns, functions, and underlying mechanisms of action of M3-mAChR in CVDs, especially ischemia/reperfusion injury, cardiac hypertrophy, and heart failure.
No takes yet. Share an insight, caveat, or question.
liu et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: